Outgoing FDA chief Gottlieb taking drug price fight to think tank
As FDA commissioner, Scott Gottlieb battled to lower the cost of prescription drugs and streamline approval of biosimilars. Now, Gottlieb is taking that fight to the private sector. In an interview with the Washington Post, Gottlieb, who will leave the Trump administration Friday, said he plans to take a fellowship with conservative think tank American Enterprise… Read More »